Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Liu ET, Liu J.

PLoS Genet. 2010 Jul 1;6(7):e1001012. doi: 10.1371/journal.pgen.1001012.

2.

Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer.

Li J, Eriksson L, Humphreys K, Czene K, Liu J, Tamimi RM, Lindström S, Hunter DJ, Vachon CM, Couch FJ, Scott CG, Lagiou P, Hall P.

Breast Cancer Res. 2010;12(2):R19. doi: 10.1186/bcr2488. Epub 2010 Mar 9.

3.

Genetic variants in ER cofactor genes and endometrial cancer risk.

Li Y, Low HQ, Foo JN, Darabi H, Einarsdόttir K, Humphreys K, Spurdle A; ANECS Group, Easton DF, Thompson DJ, Dunning AM, Pharoah PD, Czene K, Chia KS, Hall P, Liu J.

PLoS One. 2012;7(8):e42445. doi: 10.1371/journal.pone.0042445. Epub 2012 Aug 2.

4.

Variants of estrogen-related genes and breast cancer risk in European and African American women.

Quan L, Hong CC, Zirpoli G, Roberts MR, Khoury T, Sucheston-Campbell LE, Bovbjerg DH, Jandorf L, Pawlish K, Ciupak G, Davis W, Bandera EV, Ambrosone CB, Yao S.

Endocr Relat Cancer. 2014;21(6):853-64. doi: 10.1530/ERC-14-0250. Epub 2014 Sep 16.

5.

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.

Darabi H, Czene K, Wedrén S, Li Y, Liu J, Hall P, Humphreys K.

Breast Cancer Res Treat. 2011 Jun;127(2):503-9. doi: 10.1007/s10549-010-1218-z. Epub 2010 Oct 20.

PMID:
20960227
6.

Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L, Spirtas R, McDonald JA, Strom BL, Burkman RT, Simon MS, Liff JM, Daling JR, Malone KE.

Cancer Causes Control. 2012 May;23(5):671-81. doi: 10.1007/s10552-012-9925-x. Epub 2012 Mar 15.

7.

HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.

Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):213-9.

8.

Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC.

Cancer Causes Control. 2015 Jan;26(1):121-31. doi: 10.1007/s10552-014-0491-2. Epub 2014 Nov 25.

9.

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.

Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, Sherman ME, Lacey JV Jr, Gaudet MM, Burdette LA, Figueroa JD, Ciampa JG, Lissowska J, Peplonska B, Chanock SJ, Garcia-Closas M.

Carcinogenesis. 2010 May;31(5):827-33. doi: 10.1093/carcin/bgp328. Epub 2010 Jan 6.

10.

Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.

Monsees GM, Kraft P, Chanock SJ, Hunter DJ, Han J.

Breast Cancer Res Treat. 2011 Jan;125(1):207-14. doi: 10.1007/s10549-010-0947-3. Epub 2010 May 23.

11.

Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women.

Sun MY, Du HY, Zhu AN, Liang HY, de Garibay GR, Li FX, Li M, Yang XX.

Int J Mol Sci. 2015 Feb 13;16(2):4121-35. doi: 10.3390/ijms16024121.

12.

Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.

Roberts MR, Sucheston-Campbell LE, Zirpoli GR, Higgins M, Freudenheim JL, Bandera EV, Ambrosone CB, Yao S.

Mol Carcinog. 2017 Mar;56(3):1000-1009. doi: 10.1002/mc.22565. Epub 2016 Sep 21.

PMID:
27597141
13.

Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.

Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT.

Cancer Res. 2003 Nov 15;63(22):7624-9.

14.

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.

Lee E, Schumacher F, Lewinger JP, Neuhausen SL, Anton-Culver H, Horn-Ross PL, Henderson KD, Ziogas A, Van Den Berg D, Bernstein L, Ursin G.

Breast Cancer Res. 2011 Apr 1;13(2):R37. doi: 10.1186/bcr2859.

15.

Hormone-related pathways and risk of breast cancer subtypes in African American women.

Haddad SA, Lunetta KL, Ruiz-Narváez EA, Bensen JT, Hong CC, Sucheston-Campbell LE, Yao S, Bandera EV, Rosenberg L, Haiman CA, Troester MA, Ambrosone CB, Palmer JR.

Breast Cancer Res Treat. 2015 Nov;154(1):145-54. doi: 10.1007/s10549-015-3594-x. Epub 2015 Oct 12.

16.

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.

Healey CS, Ahmed S; ANECS; AOCS Management Group, O'Mara TA, Ferguson K; LES, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F; NSECG, Howarth K, Gorman M, Hodgson S, Tomlinson I; PECS, Yang HP, Lissowska J, Brinton LA, Chanock S, Garcia-Closas M; SASBAC, Hall P, Liu J; SEARCH, Shah M, Pharoah PD, Thompson DJ; WISE, Rebbeck TR, Strom BL, Dunning AM, Easton DF, Spurdle AB.

Carcinogenesis. 2011 Dec;32(12):1862-6. doi: 10.1093/carcin/bgr214. Epub 2011 Sep 30.

17.

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H.

Breast Cancer Res Treat. 2008 Mar;108(1):137-49. Epub 2007 Jun 23.

PMID:
17588204
18.

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.

Li Y, Li Y, Wedrén S, Li G, Charn TH, Desai KV, Bonnard C, Czene K, Humphreys K, Darabi H, Einarsdóttir K, Heikkinen T, Aittomäki K, Blomqvist C, Chia KS, Nevanlinna H, Hall P, Liu ET, Liu J.

Breast Cancer Res. 2011 Jan 26;13(1):R10. doi: 10.1186/bcr2817.

19.

Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.

Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, Pinkston CM, John EM, Hines LM, Stern MC, Giuliano AR, Torres-Mejia G, Brock GN, Groves FD, Kerber RA, Wolff RK, Slattery ML.

Breast Cancer Res Treat. 2013 Sep;141(2):287-97. doi: 10.1007/s10549-013-2690-z. Epub 2013 Sep 14.

20.

Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.

Miyoshi Y, Noguchi S.

Biomed Pharmacother. 2003 Dec;57(10):471-81. Review.

PMID:
14637391

Supplemental Content

Support Center